$116 Million is the total value of DAFNA Capital Management LLC's 94 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 44.2% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ATRC | Buy | ATRICURE INC | $8,221,000 | -24.9% | 488,446 | +0.1% | 7.09% | -27.3% |
| ABBV | ABBVIE INC | $6,659,000 | -3.6% | 116,581 | 0.0% | 5.74% | -6.7% | |
| NXTM | Buy | NXSTAGE MEDICAL INC | $5,944,000 | -26.0% | 396,554 | +8.2% | 5.13% | -28.4% |
| VTAE | Buy | VITAE PHARMACEUTICALS INC | $5,220,000 | +49.3% | 787,373 | +307.5% | 4.50% | +44.5% |
| RIGL | Buy | RIGEL PHARMACEUTICALS INC | $3,903,000 | +16.1% | 1,876,492 | +69.1% | 3.37% | +12.3% |
| DERM | New | DERMIRA INC | $3,554,000 | – | 171,881 | +100.0% | 3.07% | – |
| PODD | INSULET CORP | $3,516,000 | -12.3% | 106,018 | 0.0% | 3.03% | -15.1% | |
| ALDR | Buy | ALDER BIOPHARMACEUTICALS INC | $3,436,000 | +477.5% | 140,313 | +679.5% | 2.96% | +459.2% |
| MRNS | MARINUS PHARMACEUTICALS INC | $3,048,000 | -29.6% | 566,498 | 0.0% | 2.63% | -31.9% | |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $3,018,000 | – | 76,300 | +100.0% | 2.60% | – |
| NVAX | New | NOVAVAX INC | $2,856,000 | – | 553,500 | +100.0% | 2.46% | – |
| BEAT | BIOTELEMETRY INC | $2,752,000 | 0.0% | 235,645 | 0.0% | 2.37% | -3.2% | |
| GLPG | Buy | GALAPAGOS NVspon adr | $2,742,000 | +45.4% | 65,568 | +118.6% | 2.36% | +40.7% |
| RGLS | Buy | REGULUS THERAPEUTICS INC | $2,713,000 | +245.6% | 391,500 | +335.0% | 2.34% | +234.3% |
| AGTC | Buy | APPLIED GENETIC TECHNOL CORP | $2,337,000 | -27.1% | 167,192 | +6.4% | 2.02% | -29.5% |
| INSULET CORPnote 2.000% 6/1 | $2,330,000 | -7.2% | 2,407,000 | 0.0% | 2.01% | -10.2% | ||
| AERI | Buy | AERIE PHARMACEUTICALS INC | $2,186,000 | -39.5% | 179,769 | +21.2% | 1.89% | -41.4% |
| MASI | MASIMO CORPORATION | $1,925,000 | +0.8% | 46,010 | 0.0% | 1.66% | -2.5% | |
| QURE | Buy | UNIQURE B.V. | $1,888,000 | +226.1% | 158,907 | +354.0% | 1.63% | +215.7% |
| ACHN | ACHILLION PHARMACEUTICALS | $1,826,000 | -28.4% | 236,500 | 0.0% | 1.58% | -30.8% | |
| CARA | Buy | CARA THERAPEUTICS INC | $1,661,000 | -41.8% | 267,046 | +57.7% | 1.43% | -43.7% |
| PROTALIX BIOTHERAPEUTICS INCnote 4.500% 9/1 | $1,644,000 | -7.4% | 2,500,000 | 0.0% | 1.42% | -10.4% | ||
| IBB | New | ISHARES TR NASDQ BIOTECetf | $1,565,000 | – | 6,000 | +100.0% | 1.35% | – |
| STXS | STEREOTAXIS INC | $1,510,000 | +47.9% | 1,372,862 | 0.0% | 1.30% | +43.2% | |
| BSTC | New | BIOSPECIFICS TECHNOLOGIES | $1,382,000 | – | 39,704 | +100.0% | 1.19% | – |
| XENE | Buy | XENON PHARMACEUTICALS INC | $1,350,000 | +71.8% | 193,195 | +97.7% | 1.16% | +66.2% |
| RDUS | New | RADIUS HEALTH INC | $1,339,000 | – | 42,600 | +100.0% | 1.16% | – |
| CYAD | CELYADadr | $1,325,000 | -19.1% | 30,000 | 0.0% | 1.14% | -21.7% | |
| LDRH | New | LDR HLDG CORP | $1,282,000 | – | 50,300 | +100.0% | 1.11% | – |
| SPNC | SPECTRANETICS CORP | $1,159,000 | -3.6% | 79,812 | 0.0% | 1.00% | -6.7% | |
| NVDQ | NOVADAQ TECHNOLOGIES INC | $1,129,000 | -13.0% | 101,841 | 0.0% | 0.97% | -15.7% | |
| DSCI | DERMA SCIENCES INC | $1,097,000 | -32.1% | 353,718 | 0.0% | 0.95% | -34.4% | |
| ARDX | New | ARDELYX INC | $1,090,000 | – | 140,265 | +100.0% | 0.94% | – |
| LOXO | Sell | LOXO ONCOLOGY INC | $1,066,000 | -39.3% | 39,000 | -36.8% | 0.92% | -41.2% |
| JNJ | JOHNSON AND JOHNSON | $1,017,000 | +5.3% | 9,400 | 0.0% | 0.88% | +1.9% | |
| MGNX | Buy | MACROGENICS INC | $1,016,000 | +36.7% | 54,200 | +125.8% | 0.88% | +32.3% |
| ASND | ASCENDIS PHARMAadr added | $988,000 | +1.3% | 53,241 | 0.0% | 0.85% | -2.0% | |
| LPCN | Buy | LIPOCINE INC | $972,000 | +50.2% | 95,731 | +91.5% | 0.84% | +45.2% |
| MNOV | New | MEDICINOVA INC | $918,000 | – | 125,000 | +100.0% | 0.79% | – |
| DSCO | New | DISCOVERY LABORATORIES INC N COM PAR | $891,000 | – | 533,358 | +100.0% | 0.77% | – |
| SGYPQ | SYNERGY PHARMACEUTICALS | $813,000 | -51.3% | 294,563 | 0.0% | 0.70% | -52.9% | |
| FOMX | Buy | FOAMIX PHARMACEUTICALS LTD | $774,000 | +57.0% | 118,671 | +95.3% | 0.67% | +52.2% |
| ALDX | New | ALDEYRA THERAPEUTICS INC | $738,000 | – | 176,232 | +100.0% | 0.64% | – |
| ZGNX | Buy | ZOGENIX INC | $734,000 | -28.3% | 79,400 | +14.4% | 0.63% | -30.6% |
| AAVL | AVALANCHE BIOTECHNOLOGIES IN | $727,000 | -45.7% | 140,600 | 0.0% | 0.63% | -47.5% | |
| ADAP | Buy | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $716,000 | +23.4% | 88,100 | +83.2% | 0.62% | +19.5% |
| ADMS | New | ADAMAS PHARMACEUTICALS INC | $687,000 | – | 47,500 | +100.0% | 0.59% | – |
| CDNA | CAREDX INC | $675,000 | -22.5% | 136,047 | 0.0% | 0.58% | -25.0% | |
| TBRA | Sell | TOBIRA THERAPEUTICS INC | $666,000 | -58.7% | 81,402 | -49.2% | 0.58% | -60.0% |
| Sell | ESSA PHARMA INC | $662,000 | -36.7% | 202,496 | -11.4% | 0.57% | -38.7% | |
| CYNA | Buy | CYNAPSUS THERAPEUTICS INC | $646,000 | -10.5% | 52,941 | +13.5% | 0.56% | -13.5% |
| DRNA | DICERNA PHARMACEUTICALS INC | $646,000 | -54.9% | 120,600 | 0.0% | 0.56% | -56.4% | |
| EXAC | EXACTECH INC | $641,000 | +11.7% | 31,636 | 0.0% | 0.55% | +8.0% | |
| EDGE | New | EDGE THERAPEUTICS INC | $633,000 | – | 69,177 | +100.0% | 0.55% | – |
| SCYX | SCYNEXIS INC | $632,000 | -35.1% | 156,904 | 0.0% | 0.54% | -37.2% | |
| ELOS | SYNERON MEDICAL LTD | $628,000 | -5.3% | 85,947 | 0.0% | 0.54% | -8.3% | |
| AKBA | New | AKEBIA THERAPEUTICS INC | $592,000 | – | 65,700 | +100.0% | 0.51% | – |
| BGNE | New | BEIGENE LTDsponsored adr added | $586,000 | – | 20,000 | +100.0% | 0.50% | – |
| IRONWOOD PHARMAnote 2.25% 15-jun-2022 144a sr unsecured conv | $548,000 | -2.7% | 600,000 | 0.0% | 0.47% | -5.8% | ||
| TARGACEPT INCnote 2/1 added | $531,000 | 0.0% | 530,821 | 0.0% | 0.46% | -3.2% | ||
| BLUE | Buy | BLUEBIRD BIO INC | $510,000 | +32.5% | 12,000 | +100.0% | 0.44% | +28.3% |
| CRDC | New | CARDICA INC COM | $499,000 | – | 140,275 | +100.0% | 0.43% | – |
| ENDOLOGIX INCnote 3.250%11/0 added | $496,000 | -9.0% | 500,000 | 0.0% | 0.43% | -11.9% | ||
| INTEC PHARMA LTD JERUSALEM | $491,000 | -23.2% | 119,296 | 0.0% | 0.42% | -25.6% | ||
| ABUS | New | ARBUTUS BIOPHARMA CORP | $476,000 | – | 115,230 | +100.0% | 0.41% | – |
| ABEO | ABEONA THERAPEUTICS INC | $465,000 | -23.9% | 181,818 | 0.0% | 0.40% | -26.4% | |
| BCRX | Sell | BIOCRYST PHARMACEUTICALS INC | $423,000 | -84.0% | 149,642 | -41.5% | 0.36% | -84.5% |
| NEOS | Sell | NEOS THERAPEUTICS INC | $419,000 | -53.9% | 38,873 | -38.7% | 0.36% | -55.4% |
| CYNAPSUS THERAPEUTICS INC | $416,000 | -20.9% | 33,995 | 0.0% | 0.36% | -23.5% | ||
| NMUS | Sell | NEMUS BIOSCIENCE INC | $400,000 | +17.3% | 580,382 | -7.1% | 0.34% | +13.5% |
| CYTK | Buy | CYTOKINETICS INC | $392,000 | -6.2% | 55,600 | +39.0% | 0.34% | -9.4% |
| CGNT | Buy | COGENTIX MEDICAL INC | $388,000 | -14.5% | 352,882 | +0.3% | 0.34% | -17.3% |
| VTVT | VTV THERAPEUTICS INCcl a added | $377,000 | -24.1% | 73,000 | 0.0% | 0.32% | -26.6% | |
| TNDM | TANDEM DIABETES CARE INC | $318,000 | -26.4% | 36,551 | 0.0% | 0.27% | -28.8% | |
| CHEK | Sell | CHECK CAP LTD | $245,000 | +18.9% | 89,220 | -18.2% | 0.21% | +14.7% |
| SNSS | New | SUNESIS PHARMACEUTICALS INC | $229,000 | – | 423,336 | +100.0% | 0.20% | – |
| APPY | New | VENAXIS INC | $201,000 | – | 74,350 | +100.0% | 0.17% | – |
| STEM | New | STEMCELLS INC | $182,000 | – | 699,563 | +100.0% | 0.16% | – |
| AFMD | New | AFFIMED THERAPEUTICS BV | $175,000 | – | 46,701 | +100.0% | 0.15% | – |
| TENX | TENAX THERAPEUTICS INC | $163,000 | -37.5% | 79,509 | 0.0% | 0.14% | -39.5% | |
| BPMX | New | BIOPHARMX CORP | $160,000 | – | 146,800 | +100.0% | 0.14% | – |
| CBIO | CATALYST BIOSCIENCES INC | $119,000 | -46.4% | 70,903 | 0.0% | 0.10% | -48.0% | |
| PIRS | New | PIERIS PHARMACEUTICALS INC | $95,000 | – | 50,214 | +100.0% | 0.08% | – |
| GNVC | GENVEC INC | $77,000 | -56.2% | 95,800 | 0.0% | 0.07% | -58.0% | |
| CVM | CEL SCI CORP | $68,000 | +44.7% | 127,482 | 0.0% | 0.06% | +40.5% | |
| DNAI | PRONAI THERAPEUTICS INC | $67,000 | -55.3% | 10,000 | 0.0% | 0.06% | -56.7% | |
| AKTX | Sell | AKARI THERAPEUTICS PLCsponsored adr added | $66,000 | -45.5% | 4,741 | -43.2% | 0.06% | -47.2% |
| GLMD | Buy | GALMED PHARMACEUTICALS LTD | $66,000 | -27.5% | 13,488 | +12.5% | 0.06% | -29.6% |
| NVLS | NIVALIS THERAPEUTICS INC | $63,000 | -45.7% | 15,000 | 0.0% | 0.05% | -47.6% | |
| CHEKW | Sell | CHECK CAP LTD*w exp 02/28/202 added | $42,000 | +10.5% | 53,690 | -0.1% | 0.04% | +5.9% |
| ATRS | ANTARES PHARMA INC | $39,000 | -27.8% | 45,000 | 0.0% | 0.03% | -29.2% | |
| ETRM | New | ENTEROMEDICS INC COM PAR 0.01 | $32,000 | – | 33,334 | +100.0% | 0.03% | – |
| New | NEURODERM LTD | $17,000 | – | 1,202 | +100.0% | 0.02% | – | |
| ETRM | Exit | ENTEROMEDICS INC | $0 | – | -500,000 | -100.0% | -0.06% | – |
| TRVN | Exit | TREVENA INC | $0 | – | -14,800 | -100.0% | -0.14% | – |
| APPY | Exit | VENAXIS INC | $0 | – | -594,800 | -100.0% | -0.16% | – |
| CRDC | Exit | CARDICA INC | $0 | – | -1,402,762 | -100.0% | -0.19% | – |
| ARNA | Exit | ARENA PHARMACEUTICALS INC | $0 | – | -381,600 | -100.0% | -0.65% | – |
| Exit | NUVASIVE INCnote 2.750% 7/0 | $0 | – | -760,000 | -100.0% | -0.93% | – | |
| CYTR | Exit | CYTRX CORP | $0 | – | -583,013 | -100.0% | -1.38% | – |
| DSCO | Exit | DISCOVERY LABORATORIES INC | $0 | – | -7,467,032 | -100.0% | -1.42% | – |
| CTIC | Exit | CTI BIOPHARMA CORP | $0 | – | -3,195,381 | -100.0% | -3.50% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2016-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| STEREOTAXIS INC | 42 | Q3 2023 | 27.6% |
| ATRICURE INC | 42 | Q3 2023 | 11.4% |
| MASIMO CORPORATION | 42 | Q3 2023 | 1.8% |
| ASCENDIS PHARMA A S SPONSORED | 34 | Q3 2023 | 4.5% |
| AERIE PHARMACEUTICALS INC | 33 | Q3 2022 | 4.2% |
| GALAPAGOS NV-SPON ADR | 33 | Q3 2023 | 3.8% |
| XENON PHARMACEUTICALS INC | 33 | Q3 2023 | 3.6% |
| NEUROCRINE BIOSCIENCES INC | 32 | Q3 2023 | 2.9% |
| JOHNSON AND JOHNSON | 32 | Q1 2021 | 1.2% |
| ISHARES TR NASDQ BIOTECH | 30 | Q3 2023 | 4.0% |
View DAFNA Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stereotaxis, Inc. | March 08, 2018 | 13,680,554 | 23.4% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2018 | 983,000 | 2.9% |
| SUNESIS PHARMACEUTICALS INC | February 14, 2017 | 1,133,583 | 5.4% |
| WINDTREE THERAPEUTICS INC /DE/ | February 14, 2017 | 208,333 | 2.4% |
| ANAVEX LIFE SCIENCES CORP.Sold out | February 16, 2016 | 0 | 0.0% |
| DISCOVERY LABORATORIES INC /DE/ | February 16, 2016 | 10,658,699 | 9.2% |
| PRECISION OPTICS CORPORATION, INC. | February 13, 2015 | 311,537 | 5.0% |
| TearLab Corp | February 14, 2013 | 939,239 | 3.2% |
| VIKING SYSTEMS INC | February 14, 2012 | 3,781,468 | 5.2% |
View DAFNA Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View DAFNA Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.